Gene · 91
Papers1,784
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,784
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery. | Stem Cells Transl Med | 2023 | 37459045 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| Protocol for inducing branching morphogenesis in human cholangiocyte and cholangiocarcinoma organoids. | STAR Protoc | 2023 | 37432852 | PubTator, text mining | PubMed |
| Improved Production of Induced Pluripotent Stem Cells Using Dot Pattern Culture Plates. | Tissue Eng Part C Methods | 2023 | 37427413 | PubTator, text mining | PubMed |
| Efficient and scalable generation of primordial germ cells in 2D culture using basement membrane extract overlay. | Cell Rep Methods | 2023 | 37426764 | PubTator, text mining | PubMed |
| Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential. | Front Cell Infect Microbiol | 2023 | 37424781 | PubTator, text mining | PubMed |
| Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas. | Biomark Res | 2023 | 37403120 | PubTator, text mining | PubMed |
| Multiplex single-cell chemical genomics reveals the kinase dependence of the response to targeted therapy. | bioRxiv | 2023 | 37398090 | PubTator, text mining | PubMed |
| Endoglin and squamous cell carcinomas. | Front Med (Lausanne) | 2023 | 37396898 | PubTator, text mining | PubMed |
| Dissecting the spermatogonial stem cell niche using spatial transcriptomics. | Cell Rep | 2023 | 37393620 | PubTator, text mining | PubMed |
| TGF-β Signaling in Progression of Oral Cancer. | Int J Mol Sci | 2023 | 37373414 | PubTator, text mining | PubMed |
| Mutational spectrum for guiding the decision of adjuvant treatment in patients with resected biliary tract carcinoma. | Cancer Med | 2023 | 37341068 | PubTator, text mining | PubMed |
| Aberrant expression of bone morphogenetic proteins in the disease progression and metastasis of breast cancer. | Front Oncol | 2023 | 37333824 | PubTator, text mining | PubMed |
| H3K27me3-modulated Hofbauer cell BMP2 signalling enhancement compensates for shallow trophoblast invasion in preeclampsia. | EBioMedicine | 2023 | 37331163 | PubTator, text mining | PubMed |
| LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER- breast cancer samples. | Cancer Rep (Hoboken) | 2023 | 37321964 | PubTator, text mining | PubMed |
| Bioinformatics and system biology approach to identify the influences among COVID-19, ARDS and sepsis. | Front Immunol | 2023 | 37261353 | PubTator, text mining | PubMed |
| Growth differentiation factor 15 induces cisplatin resistance through upregulation of xCT expression and glutathione synthesis in gastric cancer. | Cancer Sci | 2023 | 37260027 | PubTator, text mining | PubMed |
| A senescence-associated signature refines the classification of different modification patterns and characterization of tumor immune microenvironment infiltration in triple-negative breast cancer. | Front Pharmacol | 2023 | 37251343 | PubTator, text mining | PubMed |
| Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population. | Nat Commun | 2023 | 37236969 | PubTator, text mining | PubMed |
| Autophagy modulators influence the content of important signalling molecules in PS-positive extracellular vesicles. | Cell Commun Signal | 2023 | 37226246 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/91/papers?page=7